Use este identificador para citar ou linkar para este item: http://repositorio.ufla.br/jspui/handle/1/43472
Registro completo de metadados
Campo DCValorIdioma
dc.creatorGhazavi, Ali-
dc.creatorGanji, Ali-
dc.creatorKeshavarzian, Nafiseh-
dc.creatorRabiemajd, Somayeh-
dc.creatorMosayebi, Ghasem-
dc.date.accessioned2020-10-20T16:33:56Z-
dc.date.available2020-10-20T16:33:56Z-
dc.date.issued2021-01-
dc.identifier.citationGHAZAVI, A. et al. Cytokine profile and disease severity in patients with COVID-19. Cytokine, [S.l.], v. 137, Jan. 2021.pt_BR
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S1043466620303392pt_BR
dc.identifier.urihttp://repositorio.ufla.br/jspui/handle/1/43472-
dc.description.abstractCytokine dysregulation is the proposed mechanism for Coronavirus disease 2019 (COVID-19). The aim of this study was to evaluate the serum levels of interferon (IFN)-γ, interleukin (IL)-5, IL-8, Il-9, IL-17, TGF-β and IFN-γ in patients infected with SARS-CoV-2. The study was conducted between 63 adult patients with COVID‐19 and compared with 33 age and gender-matched healthy subjects as controls. The age range in both groups was 50–70 years. The patients were classified into mild group (33 patients) and severe group (30 patients). Serum samples were collected from all participants and tested for the cytokine levels by ELISA (enzyme-linked immunosorbent assay) method. Statistical analysis was performed using the one-way ANOVA. The mean serum levels of IFN-γ, TGF-β, IL-17 and IL-8 in the COVID‐19 patients were significantly higher than those observed in the control group. A comparison of between the mild and severe groups showed significant differences in TGF-β levels. The mean concentration of serum IL-5 and IL-9 in patients with COVID‐19 did not differ from those in the control group. Systemic IL-17 levels correlated positively and significantly with TGF-β in patients with COVID‐19. Th1 (IFN-γ), Treg (TGF-β), and Th17 (IL-17) cytokines concentration were increased in COVID-19 patients. Interferon-γ and IL-17 are involved in inducing and mediating proinflammatory responses. Our data suggest that TGF-β can be used as a predictive factor of disease severity in patients with COVID-19.pt_BR
dc.languageen_USpt_BR
dc.publisherElsevierpt_BR
dc.rightsrestrictAccesspt_BR
dc.sourceCytokinept_BR
dc.subjectCOVID-19pt_BR
dc.subjectCytokinespt_BR
dc.subjectDisease severitypt_BR
dc.titleCytokine profile and disease severity in patients with COVID-19pt_BR
dc.typeArtigopt_BR
Aparece nas coleções:FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19)

Arquivos associados a este item:
Não existem arquivos associados a este item.


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.